Letter from the editor.
Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel.
Ronald
R
Ellis
Acquisitions Editor; Landes Bioscience; Vienna, Austria.
Eva M
EM
Riedmann
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D003141:Communicable Diseases / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D014612:Vaccines